Research Database

38 studies found

Positive

47.4%

Negative

0.0%

Inconclusive

50.0%

Page 2 of 2

PositiveReview/Other

Cannabis Use for Endometriosis: Clinical and Legal Challenges in Australia and New Zealand

2022

AnxietyCOVID-19Cancer+8

PositiveAnimal Study -

Treatment of Ovarian Hyperstimulation Syndrome in a Mouse Model by Cannabidiol, an Angiogenesis Pathway Inhibitor

2022

Ovarian Dysfunction

PositiveAnimal Study - Veterinary Clinical Trial

Role of the endocannabinoid system in the pathophysiology of endometriosis and therapeutic implications

2022

Endometriosis

PositiveMeta-analysis -

Medical Cannabis for Gynecologic Pain Conditions: A Systematic Review

2022

Cancer

InconclusiveAnimal Study - Veterinary Clinical Trial

The endocannabinoid system, cannabis, and cannabidiol: Implications in urology and men's health

2021

Anxiety

InconclusiveMeta-analysis -

Cannabinoids, cannabis, and cannabis-based medicines for pain management: an overview of systematic reviews

2021

Addiction

PositiveAnimal Study - Veterinary Clinical Trial

Cannabidiol Use, Substitution for Medications, and Perceptions of Effectiveness in Women with Chronic Pelvic Pain

2021

Pain

PositiveReview/Other

Medical Cannabis, Headaches, and Migraines: A Review of the Current Literature

2021

Alzheimer's Disease

PositiveReview/Other

Illicit Cannabis Usage as a Management Strategy in New Zealand Women with Endometriosis: An Online Survey

2020

Endometriosis

PositiveReview/Other

Self-Reported Efficacy of Cannabis for Endometriosis Pain

2019

Endometriosis

PositiveReview/Other

Self-management strategies amongst Australian women with endometriosis: a national online survey

2019

Endometriosis

PositiveReview/Other

The Clinical Significance of Endocannabinoids in Endometriosis Pain Management

2017

Endometriosis

PositiveMeta-analysis -

Micronized palmitoylethanolamide/trans-polydatin treatment of endometriosis-related pain: a meta-analysis

2017

Endometriosis

InconclusiveClinical Trial

Progesterone-dependent Regulation of Endometrial Cannabinoid Receptor Type 1 (CB1-R) Expression is Disrupted in Women with Endometriosis and in Isolated Stromal Cells Exposed to TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin)

2012

Endometriosis

PositiveReview/Other

Effect of palmitoylethanolamide-polydatin combination on chronic pelvic pain associated with endometriosis: preliminary observations

2010

Endometriosis

PositiveReview/Other

Antiproliferative Effects of Cannabinoid Agonists on Deep Infiltrating Endometriosis.

2010

Endometriosis

PositiveReview/Other

Endocannabinoid involvement in endometriosis.

2010

Endometriosis

InconclusiveClinical Trial

Selective CB2 up‐regulation in women affected by endometrial inflammation

2007

Endometriosis

Command Palette

Research Database

Cannabis Use for Endometriosis: Clinical and Legal Challenges in Australia and New Zealand

Treatment of Ovarian Hyperstimulation Syndrome in a Mouse Model by Cannabidiol, an Angiogenesis Pathway Inhibitor

Role of the endocannabinoid system in the pathophysiology of endometriosis and therapeutic implications

Medical Cannabis for Gynecologic Pain Conditions: A Systematic Review

The endocannabinoid system, cannabis, and cannabidiol: Implications in urology and men's health

Cannabinoids, cannabis, and cannabis-based medicines for pain management: an overview of systematic reviews

Cannabidiol Use, Substitution for Medications, and Perceptions of Effectiveness in Women with Chronic Pelvic Pain

Medical Cannabis, Headaches, and Migraines: A Review of the Current Literature

Illicit Cannabis Usage as a Management Strategy in New Zealand Women with Endometriosis: An Online Survey

Self-Reported Efficacy of Cannabis for Endometriosis Pain

Self-management strategies amongst Australian women with endometriosis: a national online survey

The Clinical Significance of Endocannabinoids in Endometriosis Pain Management

Micronized palmitoylethanolamide/trans-polydatin treatment of endometriosis-related pain: a meta-analysis

Progesterone-dependent Regulation of Endometrial Cannabinoid Receptor Type 1 (CB1-R) Expression is Disrupted in Women with Endometriosis and in Isolated Stromal Cells Exposed to TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin)

Effect of palmitoylethanolamide-polydatin combination on chronic pelvic pain associated with endometriosis: preliminary observations

Antiproliferative Effects of Cannabinoid Agonists on Deep Infiltrating Endometriosis.

Endocannabinoid involvement in endometriosis.

Selective CB2 up‐regulation in women affected by endometrial inflammation